Skip to main content

Advertisement

SpringerLink
Log in

Molecular cardiovascular imaging is ready for prime time: almost there

  • Debate Article
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. James ML, Gambhir SS. A molecular imaging primer: Modalities, imaging agents, and applications. Physiol Rev 2012;92:897-965.

    Article  CAS  PubMed  Google Scholar 

  2. Kircher MF, Hricak H, Larson SM. Molecular imaging for personalized cancer care. Mol Oncol 2012;6:182-95.

    Article  CAS  PubMed  Google Scholar 

  3. van Kruchten M, de Vries EG, Brown M, de Vries EF, Glaudemans AW, Dierckx RA, et al. PET imaging of oestrogen receptors in patients with breast cancer. Lancet Oncol 2013;14:e465-75.

    Article  PubMed  Google Scholar 

  4. Nasrallah IM, Wolk DA. Multimodality imaging of Alzheimer disease and other neurodegenerative dementias. J Nucl Med 2014;55:2003-11.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Sanchez-Juan P, Ghosh PM, Hagen J, Gesierich B, Henry M, Grinberg LT, et al. Practical utility of amyloid and FDG-PET in an academic dementia center. Neurology 2014;82:230-8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. http://www.acr.org/About-Us/Media-Center/Press-Releases/2015-Press-Releases/20150416-Alzheimers-Association-and-ACR-Lead-Trial-to-Inform-Medicare-Brain-Amyloid-Imaging-Coverage.

  7. Morrison AR, Wu JC, Sadeghi MM. Cardiovascular molecular imaging. In: Iskandrian AE, Garcia EV, editors. Nuclear cardiac imaging: Principles and applications. New York: Oxford University Press; 2015.

  8. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.

    Article  CAS  PubMed  Google Scholar 

  9. Allman KC. Noninvasive assessment myocardial viability: Current status and future directions. J Nucl Cardiol 2013;20:618-37 (quiz 38-9).

    Article  PubMed  Google Scholar 

  10. Golestani R, Sadeghi MM. Emergence of molecular imaging of aortic aneurysm: Implications for risk stratification and management. J Nucl Cardiol 2014;21:251-67 (quiz 68-70).

    Article  PubMed Central  PubMed  Google Scholar 

  11. Wollenweber T, Bengel FM. Molecular imaging to predict ventricular arrhythmia in heart failure. J Nucl Cardiol 2014;21:1096-109.

    Article  PubMed  Google Scholar 

  12. Tavakoli S, Vashist A, Sadeghi MM. Molecular imaging of plaque vulnerability. J Nucl Cardiol 2014;21:1112-28 (quiz 29).

    Article  PubMed Central  PubMed  Google Scholar 

  13. Schatka I, Bengel FM. Advanced imaging of cardiac sarcoidosis. J Nucl Med 2014;55:99-106.

    Article  PubMed  Google Scholar 

  14. Bokhari S, Shahzad R, Castano A, Maurer MS. Nuclear imaging modalities for cardiac amyloidosis. J Nucl Cardiol 2014;21:175-84.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Nakajima K, Nakata T. Cardiac 123I-MIBG imaging for clinical decision making: 22-year experience in Japan. J Nucl Med 2015;56:11S-9S.

    Article  CAS  PubMed  Google Scholar 

  16. Kestler M, Munoz P, Rodriguez-Creixems M, Rotger A, Jimenez-Requena F, Mari A, et al. Role of 18F-FDG PET in patients with infectious endocarditis. J Nucl Med 2014;55:1093-8.

    Article  CAS  PubMed  Google Scholar 

  17. Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol 2012;59:1616-25.

    Article  PubMed  Google Scholar 

  18. Figueroa AL, Subramanian SS, Cury RC, Truong QA, Gardecki JA, Tearney GJ, et al. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: A comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging 2012;5:69-77.

    Article  PubMed  Google Scholar 

  19. Golestani R, Razavian M, Nie L, Zhang J, Jung JJ, Ye Y, et al. Imaging vessel wall biology to predict outcome in abdominal aortic aneurysm. Circ Cardiovasc Imaging 2015;8.

  20. Tunis S, Whicher D. The National Oncologic PET Registry: Lessons learned for coverage with evidence development. J Am Coll Radiol 2009;6:360-5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Cardiovascular Medicine and Cardiovascular Research Center, Yale School of Medicine, New Haven, CT, USA

    Mehran M. Sadeghi MD

  2. Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA

    Mehran M. Sadeghi MD

Authors
  1. Mehran M. Sadeghi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mehran M. Sadeghi MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sadeghi, M.M. Molecular cardiovascular imaging is ready for prime time: almost there. J. Nucl. Cardiol. 23, 67–70 (2016). https://doi.org/10.1007/s12350-015-0237-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-015-0237-x

Keywords

Search

Navigation